TGF-{beta} antagonists as mitigators of radiation-induced tissue damage
Abstract
A method for treating tissue damage caused by radiation is described by use of a TGF-{beta} antagonist, such as an anti-TGF-{beta} antibody or a TGF-{beta} latency associated protein. It is administered not more than a week after exposure, and is particularly useful in mitigating the side effects of breast cancer therapy.
- Inventors:
- Issue Date:
- Research Org.:
- Univ. of California (United States)
- OSTI Identifier:
- 462854
- Patent Number(s):
- 5616561
- Application Number:
- PAN: 8-414,020; TRN: 97:007360
- Assignee:
- Univ. of California, Oakland, CA (United States)
- DOE Contract Number:
- AC03-76SF00098
- Resource Type:
- Patent
- Resource Relation:
- Other Information: PBD: 1 Apr 1997
- Country of Publication:
- United States
- Language:
- English
- Subject:
- 55 BIOLOGY AND MEDICINE, BASIC STUDIES; 56 BIOLOGY AND MEDICINE, APPLIED STUDIES; RADIATION INJURIES; GROWTH FACTORS; MAMMARY GLANDS; RADIOTHERAPY; NEOPLASMS; RESPONSE MODIFYING FACTORS; BIOLOGICAL RADIATION EFFECTS; THERAPEUTIC USES
Citation Formats
Barcellos-Hoff, M H. TGF-{beta} antagonists as mitigators of radiation-induced tissue damage. United States: N. p., 1997.
Web.
Barcellos-Hoff, M H. TGF-{beta} antagonists as mitigators of radiation-induced tissue damage. United States.
Barcellos-Hoff, M H. Tue .
"TGF-{beta} antagonists as mitigators of radiation-induced tissue damage". United States.
@article{osti_462854,
title = {TGF-{beta} antagonists as mitigators of radiation-induced tissue damage},
author = {Barcellos-Hoff, M H},
abstractNote = {A method for treating tissue damage caused by radiation is described by use of a TGF-{beta} antagonist, such as an anti-TGF-{beta} antibody or a TGF-{beta} latency associated protein. It is administered not more than a week after exposure, and is particularly useful in mitigating the side effects of breast cancer therapy.},
doi = {},
journal = {},
number = ,
volume = ,
place = {United States},
year = {1997},
month = {4}
}